Thursday, November 16, 2017 9:51:36 AM
Agora Financial hosted a pitch by Louis Basenese to sell his service to new subscribers. I read the transcript of the pitch. Without naming the stock he describes a company that sounds exactly like CTSO.
Louis: Yes, the tiny company that I said has a shot to deliver gains of 1,233% or higher…
The thing with this opportunity … it has a chance to return the biggest chartbreaking gains I’ve seen to date…
Robert: What about this company has you so excited?
Louis: For starters, it’s one of the TINIEST companies I’ve ever recommended.
The total worth of this small biotech is roughly $150 million.
And get this …
They’re perfectly positioned to claim a lion’s share of a $20 billion market.
That means they’re the perfect takeover target for huge gains.
Robert: Correct me if I’m wrong but you’re saying the opportunity they have is worth 133 times the value of the entire company?
Louis: Yes, and here’s the bottom line…
If the takeover announcement comes at just 10% of the market… meaning this $150 million company gets bought out for just $2 billion…
And that’s conservatively speaking…
We’re looking at a gain of 1,233%.
That turns this $4.80 stock… into a $59.18 stock… virtually overnight.
Now I’ve got to ask, what’s the secret that’s making this company tick?
Louis: Without getting into a full biology lesson here, this biotech company can help prevent life threatening conditions like liver failure… sepsis… the flu… just to name a few…
Basically, this company has developed a best of breed technology that “cleans your blood.”
It removes all the deadly “side effects” that live in our blood stream…
And then with the help of a special machine… pumps the clean blood back into your body.
In fact, their technology has already proven capable of “purifying” all the blood in your entire body… more than 70 times… in just one day’s worth of treatment.
See -- that $20 billion opportunity I just told you about…
That’s just ONE market opportunity for this tiny sub $150 million firm…
See, their technology has also proven effective for open heart surgery… part of a $57 billion market…
Not to mention dozens of potential future applications like:
Cancer Immunotherapy… which generates upwards of $100 billion in drug sales EACH year…
Cancer Cachexia… a muscle destroying condition that affects nearly HALF of all cancer patients…
Multiple Sclerosis… a potential $24.8 billion market…
Lupus… a potential $3.2 billion market…
Inflammatory Bowel Disease… a potential $1.5 billion market…
Robert: So let me get this right… We’re talking about a $150 million company potentially having $199.5 BILLION worth of opportunity.
Louis: Yep. And that’s not even counting all the other products the company has in the pipeline.
Now I don’t have time to get into all that here…
But the company’s work is so highly respected, it’s currently receiving millions of dollars to fast-track it’s products from The Joint Program for Chemical and Biological Defense… DARPA… even the U.S. Army…
I can imagine it’s only a matter of time before this company gets bought out.
Louis: Exactly. And when it does… BOOM!
Massive chartbreaking gains.
In fact, according to my research, the company is already fielding interest from dozens of players…
Which is why the time to get in for the biggest gains is NOW.
And here’s the thing…
Because this company is so tiny, it’s critical for folks to act immediately so they DON’T go chasing the stock once it shoots up over my recommended strict buy up to price.
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM